USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: Galenea Corporation
City: CAMBRIDGE
State: MA
Zip+4: 02139-
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (530) 545-1999

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,712,079.00 3

Award List:

Development of siRNAs to Prevent and Treat Influenza

Award Year / Program / Phase: 2005 / SBIR / Phase I
Agency: HHS
Principal Investigator: Qing Ge
Award Amount: $383,410.00
Abstract:
DESCRIPTION (provided by applicant): Influenza A virus causes one of the most wide-spread infections in humans. It is also a possible bioterrorism agent. In a typical year, it infects 10-20% of the population in the US, causing up to 40,000 deaths. During the 1918 influenza virus pandemic, over 40… More

Novel serotonergic, pro-cognitive antipsychotic therapies

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Silvana Leit – 617-374-1010
Award Amount: $699,792.00
Abstract:
DESCRIPTION (provided by applicant): This application, Novel serotonergic, pro-cognitive antipsychotic therapies , is in response to PA-08-142: Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44]). Schizophrenia is a devastating brain disorder that affects approximately 0.7% of… More

In vitro tools for preclinical analysis of cognitive therapies for schizophrenia

Award Year / Program / Phase: 2011 / SBIR / Phase I
Agency: HHS
Principal Investigator: Jonathan M. Levenson – 617-945-9763
Award Amount: $628,877.00
Abstract:
DESCRIPTION (provided by applicant): Schizophrenia is a debilitating disease that afflicts 1% of the US population. Symptoms of schizophrenia are classified into three categories: positive (delusions and hallucinations), negative (flattened affect, socialisolation) and cognitive (impaired attention,… More